Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

Author： Landgraf R.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.17, Iss.5, 2000-11, pp. : 411-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Orlistat in the treatment of Type 2 diabetes mellitus

By Jneidi Muna   Kelley David E  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin in the treatment of type 2 diabetes mellitus

By Stamataros George   Schneider Stephen H  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1967-1973

Informa Healthcare

Access to resources Recommend Favorite

The Economics of Screening and Treatment in Type 2 Diabetes Mellitus

By Raikou M.   McGuire A.  

PharmacoEconomics, Vol. 21, Iss. 8, 2003-01 ,pp. : 543-564

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

By Neuser Dieter  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 579-587

Adis International

Access to resources Recommend Favorite